XCNQ
BBM
Market cap3mUSD
May 28, Last price
0.01CAD
Name
Blueberries Medical Corp
Chart & Performance
Profile
Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products. The company is headquartered in Bogotá, Colombia.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2018‑03 | 2017‑03 | 2016‑03 | |
Income | |||||||||
Revenues | 288 22.44% | 235 69.70% | |||||||
Cost of revenue | 1,441 | 1,482 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (1,152) | (1,247) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | (550) | ||||||||
Tax Rate | |||||||||
NOPAT | (1,152) | (697) | |||||||
Net income | (1,635) 78.23% | (918) -82.76% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 1,981 | 1,467 | |||||||
BB yield | -45.17% | -43.43% | |||||||
Debt | |||||||||
Debt current | 2 | 1,197 | |||||||
Long-term debt | 24 | 329 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (793) | 114 | |||||||
Cash flow | |||||||||
Cash from operating activities | (1,333) | (1,469) | |||||||
CAPEX | (22) | ||||||||
Cash from investing activities | 383 | 102 | |||||||
Cash from financing activities | 539 | 1,346 | |||||||
FCF | (901) | (58) | |||||||
Balance | |||||||||
Cash | 818 | 1,413 | |||||||
Long term investments | |||||||||
Excess cash | 804 | 1,401 | |||||||
Stockholders' equity | (5,001) | (5,368) | |||||||
Invested Capital | 6,960 | 8,172 | |||||||
ROIC | |||||||||
ROCE | |||||||||
EV | |||||||||
Common stock shares outstanding | 219,299 | 168,887 | |||||||
Price | 0.02 0.00% | 0.02 -71.43% | |||||||
Market cap | 4,386 29.85% | 3,378 -67.51% | |||||||
EV | 3,593 | 3,491 | |||||||
EBITDA | (1,003) | (951) | |||||||
EV/EBITDA | |||||||||
Interest | 264 | 360 | |||||||
Interest/NOPBT |